Influence of OASL gene polymorphisms on host response to interferon therapy in chronic hepatitis C virus patients

1. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016 Sep 14;22(34):7824-40. PubMed PMID: 27678366. Pubmed Central PMCID: 5016383. Epub2016/09/30. eng.10.3748/wjg.v22.i34.7824Search in Google Scholar

2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41-52.10.1056/NEJM200107053450107Search in Google Scholar

3. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77-87.10.1002/hep.27259Search in Google Scholar

4. EASL. EASL Recommendations on Treatment of Hepatitis C 2015. J Hepatol. 2015;63(1):199-236.10.1016/j.jhep.2015.03.025Search in Google Scholar

5. Simmonds P. Genetic diversity and evolution of hepatitis C virus-- 15 years on. J Gen Virol. 2004 Nov;85(Pt 11):3173-88. PubMed PMID: 15483230. Epub 2004/10/16. eng.10.1099/vir.0.80401-0Search in Google Scholar

6. Ghany MG, Kim HY, Stoddard A, Wright EC, Seeff LB, Lok AS. Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial. Hepatology. 2011 Nov;54(5):1527-37. PubMed PMID: 22045670. Pubmed Central PMCID: 3718548. Epub 011/11/03.10.1002/hep.24550Search in Google Scholar

eng.Search in Google Scholar

7. Song Y, Cai X, Chu J, Zhuang Y, Zhang S. [Relationship between key enzyme activities of inosine-producing pathway and inosine accumulation]. Wei Sheng Wu Xue Bao. 2003 Jun;43(3):361-5. PubMed PMID: 16279203. Epub 2005/11/11. chi.Search in Google Scholar

8. Zhang Q, Weyant R, Steigerwalt AG, White LA, Melcher U, Bruton BD, et al. Genotyping of Serratia marcescens Strains Associated with Cucurbit Yellow Vine Disease by Repetitive Elements-Based Polymerase Chain Reaction and DNA-DNA Hybridization. Phytopathology. 2003 Oct;93(10):1240-6. PubMed PMID: 18944323.Epub 2008/10/24. eng.10.1094/PHYTO.2003.93.10.1240Search in Google Scholar

9. Lu J, Liu X, Shao W, Zhang P, Wei D. [Genetic characterization of the entire genome of an H9N2 avian influenza virus A/Chicken/ Shanghai/F/98]. Wei Sheng Wu Xue Bao. 2003 Aug;43(4):434-41. PubMed PMID: 16276916. Epub 2005/11/10. chi.Search in Google Scholar

10. Zhang Y, Wang Y, Yu Z, Liu Y, Wang J, Ding J. [A dicarboxylate monoamide amidohydrolase (half-amidase) from Alcaligenes eutrophus 112R4]. Wei Sheng Wu Xue Bao. 2003 Feb;43(1):87-93. PubMed PMID: 16276876. Epub 2005/11/10. chi.Search in Google Scholar

11. Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology. 2003 Sep;38(3):645-52. PubMed PMID: 12939591. Epub 2003/08/27. eng.10.1053/jhep.2003.50364Search in Google Scholar

12. Tang RH, Zhang JC, Zhuang WJ, Wu WR. [Progress of the SUPERMAN epigenetic mutation in Arabidopsis]. Yi Chuan. 2003 Sep;25(5):620-2. PubMed PMID: 15639944. Epub 2005/01/11. chi.Search in Google Scholar

13. Zhang T, Kazuyoshi K, Mahboob HQ, Tang Y, Atsushi S. Combined therapy of interleukin-12 and interleukin-18 against Cryptococcus neoformans infection in a murine model. Chin Med J (Engl). 2003 May;116(5):669-72. PubMed PMID: 12875675. Epub 2003/07/24.eng.Search in Google Scholar

14. Yan C, Wang R, Li J, Deng Y, Wu D, Zhang H, et al. HLA-A gene polymorphism defined by high-resolution sequence-based typing in161 Northern Chinese Han people. Genomics Proteomics Bioinformatics. 2003 Nov;1(4):304-9. PubMed PMID: 15629059. Epub2005/01/05. eng.10.1016/S1672-0229(03)01036-2Search in Google Scholar

15. Zhang HW, Tan ZB, Chen RJ, Li JS, Chen G. [Maize starch biosynthesis and its genetic manipulation]. Yi Chuan. 2003 Jul;25(4):455-60. PubMed PMID: 15639908. Epub 2005/01/11. chi.Search in Google Scholar

16. Li PC, Zhang XG, Zhou L, Zeng Y. [Gene optimization is necessary to express HPV type 6 L1 protein in the methylotrophic yeast Pichia pastoris]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003 Dec;17(4):310-4. PubMed PMID: 15340539. Epub2004/09/02. chi.Search in Google Scholar

17. Wang T, Ke Q, Wu L, Zhang X. [The trkC expression in spared dorsal root ganglion following acupuncture]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jan;34(1):40-2. PubMed PMID: 15600175. Epub 2004/12/17. chi.Search in Google Scholar

18. Luo XJ, Yuan SS, Yi XY, Zeng XF, Zhang SK, Tang LF, et al. [Study on the subcloning, expression and immunoprotection with Schistosoma japonicum CAI gene]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2003;21(6):353-6. PubMed PMID: 15108549. Epub 2004/04/28. chi.Search in Google Scholar

19. Zhang J, Xu LM. [Advances of mechanism research on treatment of experimental liver fibrosis with traditional Chinese medicine]. Zhong Xi Yi Jie He Xue Bao. 2003 Jul;1(2):142-5. PubMed PMID: 15339591. Epub 2004/09/02. chi.10.3736/jcim2003021815339591Search in Google Scholar

20. Su X, Yee LJ, Im K, Rhodes SL, Tang Y, Tong X, et al. Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C. J Hepatol. 2008 Aug;49(2):184-91. PubMed PMID: 18571276. Pubmed Central PMCID: 2609954. Epub 2008/06/24. eng.10.1016/j.jhep.2008.04.011260995418571276Search in Google Scholar

21. Muir AJ, Gong L, Johnson SG, Lee MT, Williams MS, Klein TE, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-alpha- based regimens. Clin Pharmacol Ther. 2014 Feb;95(2):141-6. PubMed PMID: 24096968. Pubmed Central PMCID: 904555. Epub2013/10/08. eng.10.1038/clpt.2013.203390455524096968Search in Google Scholar

22. Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol. 2004 Dec;78(24):13779-92. PubMed PMID: 15564486. Pubmed Central PMCID: 533929. Epub2004/11/27. eng.10.1128/JVI.78.24.13779-13792.200453392915564486Search in Google Scholar

23. Giannelli G, Guadagnino G, Dentico P, Antonelli G, Antonaci S. MxA and PKR expression in chronic hepatitis C. J Interferon Cytokine Res. 2004 Nov;24(11):659-63. PubMed PMID: 15684819. Epub2005/02/03. eng.10.1089/jir.2004.24.65915684819Search in Google Scholar

24. Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology. 2005 May;128(5):1437-44. PubMed PMID: 15887125. Epub 2005/05/12. eng.10.1053/j.gastro.2005.01.05915887125Search in Google Scholar

25. Marie I, Rebouillat D, Hovanessian AG. The expression of both domains of the 69/71 kDa 2’,5’ oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response. Eur J Biochem. 1999 May;262(1):155-65. PubMed PMID: 10231377. Epub 1999/05/07. eng.10.1046/j.1432-1327.1999.00361.x10231377Search in Google Scholar

26. Rebouillat D, Hovanessian AG. The human 2’,5’-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res. 1999 Apr;19(4):295-308. PubMed PMID: 10334380. Epub 1999/05/20. eng.10.1089/10799909931399210334380Search in Google Scholar

27. Choi UY, Kang JS, Hwang YS, Kim YJ. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp Mol Med. 2015;6(47):110.10.1038/emm.2014.110435140525744296Search in Google Scholar

28. Ghany MG. Diagnosis, management, and treatment of hepatitis C: An update. . Hepatology 2009;49(4):1335-74. 10.1002/hep.22759747789319330875Search in Google Scholar

29. Ryther RC, Flynt AS, Harris BD, Phillips JA, 3rd, Patton JG. GH1 splicing is regulated by multiple enhancers whose mutation produces a dominant-negative GH isoform that can be degraded by allele-specific small interfering RNA (siRNA). Endocrinology. 2004 Jun;145(6):2988-96. PubMed PMID: 14988388. Epub 004/02/28.eng.10.1210/en.2003-172414988388Search in Google Scholar

30. Yakub I, Lillibridge KM, Moran A, Gonzalez OY, Belmont J, Gibbs RA, et al. Single nucleotide polymorphisms in genes for 2’-5’-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis. 2005 Nov 15;192(10):1741-8. PubMed PMID: 16235172. Epub 2005/10/20. eng.10.1086/49734016235172Search in Google Scholar

31. Hijikata M, Ohta Y, Mishiro S. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon. Intervirology. 2000;43(2):124-7. PubMed PMID: 10971132. Epub 2000/09/06. eng.10.1159/00002503510971132Search in Google Scholar

32. Knapp S, Yee LJ, Frodsham AJ, Hennig BJ, Hellier S, Zhang L, et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 2003 Sep;4(6):411-9. PubMed PMID: 12944978. Epub 2003/08/29. eng. 10.1038/sj.gene.636398412944978Search in Google Scholar

33. Domagalski K, Pawlowska M, Zalesna A, Pilarczyk M, Rajewski P, Halota W, et al. Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus. World J Gastroenterol. 2016;22(41):9186-95.10.3748/wjg.v22.i41.9186510759927895405Search in Google Scholar